Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-03-24
1979-01-02
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31255
Patent
active
041328027
ABSTRACT:
A mucolytic process is disclosed which comprises contacting N-(2-hydroxyethyl)mercaptoacetamidobenzamides or mercaptoacylamidobenzoic acids, mercaptoacetylsulfanilic acids and alkanoylthio derivatives thereof with mucus. Illustrative of compounds useful in the mucolytic process of the present invention are 4-(2-mercaptoacetamido)benzoic acid and N-(2-mercaptoacetyl)sulfanilic acid.
REFERENCES:
patent: 2448939 (1948-09-01), Weissberger et al.
patent: 2520293 (1950-08-01), Weiss
patent: 2607789 (1952-08-01), Weiss
patent: 3091569 (1963-05-01), Sheffner
patent: 3663690 (1972-05-01), Eichel et al.
patent: 3770824 (1973-11-01), Phillips et al.
patent: 3809697 (1971-10-01), Martin et al.
A. L. Sheffner, Ann. New York Acad. Sci., 106, 298-310, (1963).
N. S. Poonia et al., Indian J. Appl. Chem. 27(1) 32-33 (1964).
Comer William T.
Martin Tellis A.
Carnahan Robert E.
Mead Johnson & Company
Robinson Allen J.
Uloth Robert H.
LandOfFree
Benzoic acid derivative and benzenesulfonic acid mucolytic proce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoic acid derivative and benzenesulfonic acid mucolytic proce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoic acid derivative and benzenesulfonic acid mucolytic proce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1518013